86 related articles for article (PubMed ID: 21650468)
21. RAGE/NF-κB pathway mediates hypoxia-induced insulin resistance in 3T3-L1 adipocytes.
Tang Y; Wang J; Cai W; Xu J
Biochem Biophys Res Commun; 2020 Jan; 521(1):77-83. PubMed ID: 31629469
[TBL] [Abstract][Full Text] [Related]
22. In vitro chronic glycation induces AGEs accumulation reducing insulin-stimulated glucose uptake and increasing GLP1R in adipocytes.
Chilelli NC; Faggian A; Favaretto F; Milan G; Compagnin C; Dassie F; Bettini S; Roverso M; Seraglia R; Lapolla A; Vettor R
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E976-E988. PubMed ID: 33779307
[TBL] [Abstract][Full Text] [Related]
23. A new indanedione derivative alleviates symptoms of diabetes by modulating RAGE-NF-kappaB pathway in db/db mice.
Khan G; Aftab MF; Bano B; Khan KM; Murtaza M; Siddiqui S; Rehman MH; Waraich RS
Biochem Biophys Res Commun; 2018 Jul; 501(4):863-870. PubMed ID: 29778537
[TBL] [Abstract][Full Text] [Related]
24. Permethrin alters adipogenesis in 3T3-L1 adipocytes and causes insulin resistance in C2C12 myotubes.
Kim J; Park Y; Yoon KS; Clark JM; Park Y
J Biochem Mol Toxicol; 2014 Sep; 28(9):418-24. PubMed ID: 24911977
[TBL] [Abstract][Full Text] [Related]
25. The effects of propionate and valerate on insulin responsiveness for glucose uptake in 3T3-L1 adipocytes and C2C12 myotubes via G protein-coupled receptor 41.
Han JH; Kim IS; Jung SH; Lee SG; Son HY; Myung CS
PLoS One; 2014; 9(4):e95268. PubMed ID: 24748202
[TBL] [Abstract][Full Text] [Related]
26. Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes.
Wang N; Xu TY; Zhang X; Li JY; Wang YX; Guo XC; Li SM; Wang WF; Li DS
Int Immunopharmacol; 2018 Mar; 56():301-309. PubMed ID: 29414665
[TBL] [Abstract][Full Text] [Related]
27. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.
Cai W; Ramdas M; Zhu L; Chen X; Striker GE; Vlassara H
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15888-93. PubMed ID: 22908267
[TBL] [Abstract][Full Text] [Related]
28. Calycosin Rebalances Advanced Glycation End Products-Induced Glucose Uptake Dysfunction of Hepatocyte In Vitro.
Xu Y; Xiong J; Zhao Y; He B; Zheng Z; Chu G; Zhu Q
Am J Chin Med; 2015; 43(6):1191-210. PubMed ID: 26446203
[TBL] [Abstract][Full Text] [Related]
29. The transcriptional response to oxidative stress is part of, but not sufficient for, insulin resistance in adipocytes.
Chaudhuri R; Krycer JR; Fazakerley DJ; Fisher-Wellman KH; Su Z; Hoehn KL; Yang JYH; Kuncic Z; Vafaee F; James DE
Sci Rep; 2018 Jan; 8(1):1774. PubMed ID: 29379070
[TBL] [Abstract][Full Text] [Related]
30. Factors in serum from type 2 diabetes patients can cause cellular insulin resistance.
Renström F; Burén J; Svensson MK; Eriksson JW
Horm Metab Res; 2009 Oct; 41(10):767-72. PubMed ID: 19764108
[TBL] [Abstract][Full Text] [Related]
31. CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes.
Kuniyasu A; Ohgami N; Hayashi S; Miyazaki A; Horiuchi S; Nakayama H
FEBS Lett; 2003 Feb; 537(1-3):85-90. PubMed ID: 12606036
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Glucose Transport in Adipocytes by Interleukin-4.
Michurina S; Stafeev I; Beloglazova I; Zubkova E; Mamontova E; Kopylov A; Shevchenko E; Menshikov M; Parfyonova Y
J Interferon Cytokine Res; 2022 Mar; 42(3):127-136. PubMed ID: 35298287
[TBL] [Abstract][Full Text] [Related]
33. Insulin resistance: Review of the underlying molecular mechanisms.
Yaribeygi H; Farrokhi FR; Butler AE; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8152-8161. PubMed ID: 30317615
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial oxidants, but not respiration, are sensitive to glucose in adipocytes.
Krycer JR; Elkington SD; Diaz-Vegas A; Cooke KC; Burchfield JG; Fisher-Wellman KH; Cooney GJ; Fazakerley DJ; James DE
J Biol Chem; 2020 Jan; 295(1):99-110. PubMed ID: 31744882
[TBL] [Abstract][Full Text] [Related]
35. Glucose as an agent of post-translational modification in diabetes--New cardiac epigenetic insights.
Mellor KM; Brimble MA; Delbridge LM
Life Sci; 2015 May; 129():48-53. PubMed ID: 24699006
[TBL] [Abstract][Full Text] [Related]
36. Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV).
Makinen MW; Brady MJ
J Biol Chem; 2002 Apr; 277(14):12215-20. PubMed ID: 11815612
[TBL] [Abstract][Full Text] [Related]
37. Structure-Activity Relationship of Synthetic Ginkgolic Acid Analogs for Treating Type 2 Diabetes by PTPN9 Inhibition.
Kim J; Son J; Ahn D; Nam G; Zhao X; Park H; Jeong W; Chung SJ
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409287
[TBL] [Abstract][Full Text] [Related]
38. Development of a physiological insulin resistance model in human stem cell-derived adipocytes.
Friesen M; Khalil AS; Barrasa MI; Jeppesen JF; Mooney DJ; Jaenisch R
Sci Adv; 2022 Jun; 8(24):eabn7298. PubMed ID: 35714187
[TBL] [Abstract][Full Text] [Related]
39. Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.
Ramalingam L; Oh E; Thurmond DC
Cell Mol Life Sci; 2013 Aug; 70(16):2815-34. PubMed ID: 23052216
[TBL] [Abstract][Full Text] [Related]
40. Current views on type 2 diabetes.
Lin Y; Sun Z
J Endocrinol; 2010 Jan; 204(1):1-11. PubMed ID: 19770178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
